Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin

Completed · Phase 4

Conditions studied: Schizophrenia, Schizoaffective Disorder

In brief

This study supplements patients' current medications with Pravastatin, a cholesterol-lowering medication, to try to improve residual symptoms of schizophrenia, and also to improve cognitive functioning.

Key facts

Study ID
NCT00177580
Run by
University of Pittsburgh
People needed
72
Starts
2003-07-01
Expected to finish
2007-07-01
Last updated by the study team
2008-01-15

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.